Oportun Financial OPRT 深 滬
已收盤 02-06 16:00:00 美东时间
5.62
+0.270
+5.05%
華盛通- 最 高5.775
- 今 開5.41
- 成交量 56.30万股
- 最 低 5.41
- 昨 收 5.35
- 總市值 2.48亿
- 52周最高 9.245
- 市盈率 靜 --
- 換手率 1.28%
- 52周最低 4.05
- 委 比 -60.32%
- 總股本 4412.90万
- 歷史最高 27.95
- 量 比 1.29
- 振 幅 6.82%
- 歷史最低 2.05
- 每 手 1
- 風險率 0.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 智能家居公司SKYX大涨25%，推出天花板风扇创新产品；OPRT大涨25%
智能家居公司SKYX大涨25%，推出天花板风扇创新产品，管理层对其预期乐观；OPRT大涨25%，公司Q4及全年业绩超预期>>
01-23 16:01
Oportun Expects to Meet or Outperform 2025 Guidance
Oportun Expects to Meet or Outperform 2025 Guidance Oportun Financial Corp. announced that, based on preliminary unaudited results as of December 31, 2025, the company is expected to meet or outperform each of its year-end 2025 guidance metrics. The company plans to release its fourth quarter and fu
01-22 05:07
Oportun Financial Announces Raul Vazquez To Step Down As CEO And Board Member No Later Than April 3; Board Initiates CEO Search
Oportun Financial Corporation (NASDAQ:OPRT) ("Oportun" or the "Company"), a mission-driven financial services company, today announced that Chief Executive Officer Raul Vazquez will step down from his roles as CEO and a
01-22 05:07
Oportun CEO Raul Vazquez to Step Down as Board Launches Successor Search
Oportun CEO Raul Vazquez to Step Down as Board Launches Successor Search Oportun Financial Corp. announced that CEO Raul Vazquez will step down from his roles as CEO and board member no later than April 3, 2026. The board has begun a search for his successor. Vazquez will serve as an advisor to the
01-22 05:06
Oportun Announces CEO Succession Plan
Oportun Financial Corporation announced that CEO Raul Vazquez will step down by April 3, 2026, and the board has commenced the CEO search. The company also provided preliminary fourth quarter and full year 2025 financial results, with revenue exceeding expectations and strong net charge-off performance. Vazquez will advise through July 3, 2026, to ensure a smooth transition.
01-21 21:05
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
JP Morgan Upgrades Oportun Financial to Neutral, Maintains Price Target to $5.5
JP Morgan analyst Richard Shane upgrades Oportun Financial (NASDAQ:OPRT) from Underweight to Neutral and maintains the price target from $5.5 to $5.5.
01-12 20:22
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
JP Morgan Maintains Underweight on Oportun Financial, Lowers Price Target to $5.5
JP Morgan analyst Richard Shane maintains Oportun Financial (NASDAQ:OPRT) with a Underweight and lowers the price target from $6 to $5.5.
2025-12-05 01:43
Oportun Financial shares are trading higher after the company reported Q3 results above estimates and raised its FY2025 adjusted EPS outlook.
Oportun Financial shares are trading higher after the company reported Q3 resul...
2025-11-05 06:00
